9-21970980-C-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 4P and 20B. PM1PM5BP4_StrongBP6_Very_StrongBS1BS2

The NM_000077.5(CDKN2A):​c.379G>T​(p.Ala127Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000951 in 1,610,798 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A127P) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.0049 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00054 ( 7 hom. )

Consequence

CDKN2A
NM_000077.5 missense

Scores

3
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:19O:1

Conservation

PhyloP100: 2.90

Publications

41 publications found
Variant links:
Genes affected
CDKN2A (HGNC:1787): (cyclin dependent kinase inhibitor 2A) This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]
CDKN2A Gene-Disease associations (from GenCC):
  • melanoma, cutaneous malignant, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • melanoma-pancreatic cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Genomics England PanelApp
  • familial atypical multiple mole melanoma syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • melanoma and neural system tumor syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 5 benign, 44 uncertain in NM_000077.5
PM5
Other missense variant is known to change same aminoacid residue: Variant chr9-21970980-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 571866.
BP4
Computational evidence support a benign effect (MetaRNN=0.0074276924).
BP6
Variant 9-21970980-C-A is Benign according to our data. Variant chr9-21970980-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 41578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00488 (743/152354) while in subpopulation AFR AF = 0.0161 (671/41588). AF 95% confidence interval is 0.0151. There are 6 homozygotes in GnomAd4. There are 331 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 743 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000077.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN2A
NM_000077.5
MANE Select
c.379G>Tp.Ala127Ser
missense
Exon 2 of 3NP_000068.1P42771-1
CDKN2A
NM_058195.4
MANE Plus Clinical
c.*23G>T
3_prime_UTR
Exon 2 of 3NP_478102.2Q8N726-1
CDKN2A
NM_001195132.2
c.379G>Tp.Ala127Ser
missense
Exon 2 of 4NP_001182061.1P42771-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDKN2A
ENST00000304494.10
TSL:1 MANE Select
c.379G>Tp.Ala127Ser
missense
Exon 2 of 3ENSP00000307101.5P42771-1
CDKN2A
ENST00000498124.1
TSL:1
c.379G>Tp.Ala127Ser
missense
Exon 2 of 4ENSP00000418915.1P42771-4
CDKN2A
ENST00000579755.2
TSL:1 MANE Plus Clinical
c.*23G>T
3_prime_UTR
Exon 2 of 3ENSP00000462950.1Q8N726-1

Frequencies

GnomAD3 genomes
AF:
0.00487
AC:
741
AN:
152236
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0161
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00366
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00129
AC:
316
AN:
244500
AF XY:
0.000991
show subpopulations
Gnomad AFR exome
AF:
0.0171
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.0000999
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000544
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.000541
AC:
789
AN:
1458444
Hom.:
7
Cov.:
31
AF XY:
0.000445
AC XY:
323
AN XY:
725684
show subpopulations
African (AFR)
AF:
0.0174
AC:
583
AN:
33460
American (AMR)
AF:
0.00181
AC:
81
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86206
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50750
Middle Eastern (MID)
AF:
0.000768
AC:
4
AN:
5210
European-Non Finnish (NFE)
AF:
0.0000450
AC:
50
AN:
1111978
Other (OTH)
AF:
0.00114
AC:
69
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
49
98
148
197
246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00488
AC:
743
AN:
152354
Hom.:
6
Cov.:
32
AF XY:
0.00444
AC XY:
331
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.0161
AC:
671
AN:
41588
American (AMR)
AF:
0.00366
AC:
56
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68026
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
36
71
107
142
178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00194
Hom.:
6
Bravo
AF:
0.00611
ESP6500AA
AF:
0.0161
AC:
71
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00155
AC:
188
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
4
not specified (5)
-
-
3
Melanoma-pancreatic cancer syndrome (3)
-
-
1
Familial melanoma (1)
-
-
1
Melanoma and neural system tumor syndrome;C1835044:Melanoma, cutaneous malignant, susceptibility to, 2;C1838547:Melanoma-pancreatic cancer syndrome (1)
-
-
1
Melanoma, cutaneous malignant, susceptibility to, 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T
Eigen
Benign
0.015
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.58
T
MetaRNN
Benign
0.0064
T
MetaSVM
Benign
-0.48
T
PhyloP100
2.9
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.8
N
REVEL
Uncertain
0.40
Sift
Benign
0.036
D
Sift4G
Benign
0.18
T
Polyphen
0.98
D
Vest4
0.29
MVP
0.97
MPC
0.69
ClinPred
0.023
T
GERP RS
4.9
PromoterAI
0.030
Neutral
Varity_R
0.17
gMVP
0.57
Mutation Taster
=30/70
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6413464; hg19: chr9-21970979; COSMIC: COSV58713816; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.